Loading...
Please wait, while we are loading the content...
Prothrombinex-VF use in warfarin reversal and other indications.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Kruger, Paul C. Viellez, Annette S. Le Herrmann, Richard P. |
| Copyright Year | 2012 |
| Abstract | OBJECTIVE To assess the use of Prothrombinex-VF powder for injection (PTX-VF) at Royal Perth Hospital and analyse the efficacy and safety profile of PTX-VF. DESIGN, SETTING AND PATIENTS A prospective observational audit of PTX-VF use, conducted by reviewing medical records and laboratory and imaging results for all patients prescribed PTX-VF from 1 November 2009 to 1 May 2010. MAIN OUTCOME MEASURES Data on indication, diagnosis, comorbidities, dose of PTX-VF, fresh frozen plasma (FFP) and vitamin K, coagulation parameters before and after PTX-VF administration, and adverse effects. RESULTS 334 vials of PTX-VF were administered to 84 patients over 107 prescriptions. Indications were warfarin reversal, intraoperative bleeding and coagulopathy (66, 20 and 21 prescriptions, respectively). PTX-VF with FFP was compared with PTX-VF alone for warfarin reversal and there was a significant decrease in international normalised ratio (INR) that was independent of group (P < 0.001). Lower doses of PTX-VF (< 25 IU/kg) were compared with higher doses (25-50 IU/kg) for warfarin reversal and decrease in INR was significant, independent of group (P = 0.002). PTX-VF was administered for intraoperative bleeding in 18 patients who had not been treated with warfarin. No hypersensitivity reactions, thrombotic complications or worsening of disseminated intravascular coagulation occurred during 7-day follow-up. CONCLUSION For warfarin reversal, lower doses of PTX-VF (< 25 IU/kg) and PTX-VF without FFP were effective. PTX-VF was also used in intraoperative bleeding and non-warfarin coagulopathy. No adverse events were associated with PTX-VF. |
| Starting Page | 261 |
| Ending Page | 268 |
| Page Count | 8 |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | https://www.mja.com.au/system/files/issues/196_07_160412/kru10797_fm.pdf |
| PubMed reference number | 22509878v1 |
| Volume Number | 196 |
| Issue Number | 7 |
| Journal | The Medical journal of Australia |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | Adverse event Blood Coagulation Disorders Disseminated Intravascular Coagulation Drug Allergy Fresh frozen plasma Gastrointestinal Hemorrhage International Normalized Ratio Patients Pentoxifylline Picrotoxin Review [Publication Type] Thrombotic Microangiopathies Ventricular Fibrillation Vitamin K Warfarin |
| Content Type | Text |
| Resource Type | Article |